Concepedia

Marjeta Vovk

MV

6

Publications

748

Citations

6

H-Index

1997

Active since

Affiliations

Institute of Oncology Ljubljana(Current)

Centro di Riferimento Oncologico

Radboud University Nijmegen

The Netherlands Cancer Institute

AZ Sint-Jan

Marjeta Vovk is an author at Institute of Oncology Ljubljana specializing in surgical oncology, medicine, and oncology.

Top concepts

Publications per year

1997–2006

6

Publications

6

Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma

Berthe M.P. Aleman, John Raemaekers, Umberto Tirelli et al. · New England Journal of Medicine · 2003 · 306 citations · Full text

Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials

Evert M. Noordijk, Patrice Carde, N. Dupouy et al. · Journal of Clinical Oncology · 2006 · 229 citations

Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients.

Slobodan Marković, G Drozina, Marjeta Vovk et al. · PubMed · 2000 · 133 citations

Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: Interim results from the ongoing EORTC-LCG and GPMC phase III trial

John Raemaekers, M Burgers, M. Henry‐Amar et al. · Annals of Oncology · 1997 · 39 citations · Full text

, , +9

Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.

John Raemaekers, M Burgers, M. Henry‐Amar et al. · PubMed · 1997 · 23 citations

Rows per page

1–5 of 6